✓ Last verified: April 18, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff

Known For: Physician-owned IV therapy clinic on Nashville’s West End offering ketamine infusions for mood disorders and chronic pain alongside general IV wellness treatments.
| Google Reviews | 4.9 ⭐ (100+ reviews) |
| Location | Nashville, Tennessee |
| Address | 2817 West End Avenue, Suite 135, Nashville, TN 37203 |
| Phone | (615) 647-8557 |
| Website | ivsolns.com |
| Treatments | IV Ketamine Infusions, IV Hydration, Vitamin Infusions, NAD+ |
| Conditions | Depression, Anxiety, PTSD, Chronic Pain, Migraines |
| Cost | Contact for pricing |
| Insurance | Self-pay for ketamine; insurance for select services |
| KAP Available | No – IV infusion model |
| Clinical Lead | Physician-owned practice |
HealingMaps Take: Intravenous Solutions stands out with near-perfect Google ratings and a prime West End location near Vanderbilt. While they offer a broader IV therapy menu, their ketamine infusion program benefits from the team’s deep expertise in intravenous medicine. Patients appreciate the upscale, spa-like atmosphere combined with genuine medical rigor.
Market Position: Intravenous Solutions is an IV-ketamine-focused clinic in the Nashville metro — the most common cash-pay protocol in the HealingMaps verified directory.
Industry pricing reference. Intravenous Solutions has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | ✓ Yes |
| Spravato (esketamine) | $0–$250 copay (insured) | — |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
Sources: CDC PLACES 2023 (Davidson County, TN, crude prevalence) · U.S. Census ACS 5 Year · HealingMaps proprietary patient inquiry data.
Behind this data: HealingMaps has analyzed 23,496 patient inquiries (Oct 2022 – Mar 2026), mapped 1,473 verified clinics across 3,142 counties, scraped 132 clinic pricing pages, and collected 658 practitioner survey responses. This snapshot reflects our multi-source methodology.
Treatment-resistant depression — typically defined as failure on two or more antidepressant trials — is the FDA-approved indication for Spravato and the most common clinical qualifier for ketamine therapy insurance coverage. Source: HealingMaps 2026 Ketamine Clinic Intelligence Report — drawn from 23,496 patient inquiries and 132 clinic website analyses.
This 4-question summary is matched to the protocols and conditions Intravenous Solutions treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Intravenous Solutions treats depression via IV ketamine (off-label, evidence-based). Insurance coverage is rare for IV/KAP — most patients pay out of pocket. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
Yes — Intravenous Solutions treats chronic pain. They use IV ketamine for pain, which typically means longer infusion times and higher cumulative doses than mental-health protocols. Common indications include complex regional pain syndrome (CRPS), fibromyalgia, and certain neuropathic pain syndromes. Pain pricing varies significantly by structure: per-infusion vs. multi-day inpatient packages — verify how this clinic structures their billing.
Yes — Intravenous Solutions treats PTSD. Ketamine for trauma differs from depression treatment: dosing is often lower per session, and pairing the protocol with trauma-focused therapy between sessions is common. A reasonable consult question: whether PTSD patients here typically use ketamine alone or alongside an outside therapist.
Yes — Intravenous Solutions treats anxiety, including generalized anxiety, social anxiety, and panic disorder. The evidence base for ketamine in anxiety is less robust than for depression, but it can be a meaningful option for patients who haven’t responded to SSRIs or benzodiazepines. Worth asking which of their protocols they typically recommend for anxiety-primary patients.
Leave a Reply